ResMed (RMD): Exploring Valuation After Recent Share Price Pullback [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
This move comes against a backdrop of steady year-to-date gains. See our latest analysis for ResMed. Momentum was clearly on ResMed's side for much of the year, with its share price up 19.05% since January and delivering a 14.08% total shareholder return over the past twelve months. That recent pullback suggests some investors may be pausing to reassess after a strong run. Overall, the story remains one of durable growth in a challenging healthcare market. If you're interested in expanding your view beyond ResMed, there's never been a better time to discover See the full list for free. With solid gains and upbeat fundamentals, the key question emerges: is ResMed undervalued given its current momentum, or has the market already factored in all the future growth potential, leaving limited room for upside? Most Popular Narrative: 6.8% Undervalued ResMed's most watched narrative places its fair value at $291.86, offering a modest premium over the last close at $272. This sets
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Calculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]Yahoo! Finance
- ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts [Yahoo! Finance]Yahoo! Finance
- ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
RMD
Earnings
- 10/30/25 - Beat
RMD
Sec Filings
- 12/4/25 - Form 4
- 12/3/25 - Form 144
- 12/2/25 - Form 4
- RMD's page on the SEC website